SONENDO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.092 USD | -4.47% |
|
+5.75% | -56.19% |
| May. 08 | Transcript : Sonendo, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
| May. 08 | Sonendo, Inc. Raises Revenue Guidance for the Full Year of 2024 | CI |
Financials (USD)
| Sales 2024 * | 30.2M | Sales 2025 * | 33.7M | Capitalization | 6.48M |
|---|---|---|---|---|---|
| Net income 2024 * | -39M | Net income 2025 * | -25M | EV / Sales 2024 * | 0.21 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.19 x |
| P/E ratio 2024 * |
-0.17
x | P/E ratio 2025 * |
-0.29
x | Employees | 208 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.3% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sonendo, Inc.
More recommendations
More press releases
| 1 day | -4.47% | ||
| 1 week | +5.75% | ||
| Current month | +7.23% | ||
| 1 month | -12.30% | ||
| 3 months | -48.89% | ||
| 6 months | +10.84% | ||
| Current year | -56.19% |
1 week
0.09
0.10
1 month
0.080.11
Current year
0.080.25
1 year
0.051.47
3 years
0.0512.24
5 years
0.0512.24
10 years
0.0512.24
| Managers | Title | Age | Since |
|---|---|---|---|
Bjarne Bergheim
CEO | Chief Executive Officer | 50 | 05-12-31 |
Olav Bergheim
FOU | Founder | 73 | 06-05-31 |
Chris Guo
DFI | Director of Finance/CFO | 48 | 21-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Carolyn Beaver
BRD | Director/Board Member | 66 | 21-10-27 |
Olav Bergheim
FOU | Founder | 73 | 06-05-31 |
Anthony Bihl
CHM | Chairman | 67 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-04 | 0.092 | -4.47% | 15,776 |
| 24-06-03 | 0.0963 | +12.24% | 51,997 |
| 24-05-31 | 0.0858 | -7.44% | 38,851 |
| 24-05-30 | 0.0927 | -5.98% | 206,587 |
| 24-05-29 | 0.0986 | +13.33% | 83,535 |
Delayed Quote OTC Markets, June 04, 2024 at 02:07 pm EDT
More quotes
Sonendo, Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. The Company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Company also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.
Calendar
2024-06-10
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.092
USD
Average target price
0.25
USD
Spread / Average Target
+171.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -56.19% | 6.79M | |
| -6.03% | 179B | |
| +1.08% | 108B | |
| -2.19% | 69.03B | |
| -5.98% | 45.83B | |
| +12.31% | 45.39B | |
| +7.74% | 43.17B | |
| +15.98% | 29.89B | |
| +14.34% | 25.49B | |
| -9.57% | 23.95B |
- Stock Market
- Equities
- SONX Stock
